Landmark BioVentures AG, founded in 2021 and headquartered in Basel, Switzerland, is an integrated and agile biotech hub-and-spoke company.
LBV takes a unique model focused on lean operations, smart capital allocation, and diversified nexus of 7 companies developing 10 first-in-class therapeutics.